MiR-20 regulates myocardiac ischemia by targeting KATP subunit Kir6.1

Li Nie , Ya-nan Zhao , Hong-yan Luo , Xin-wu Hu , Liang-pin Zhang , Hua-min Liang

Current Medical Science ›› 2017, Vol. 37 ›› Issue (4) : 486 -490.

PDF
Current Medical Science ›› 2017, Vol. 37 ›› Issue (4) : 486 -490. DOI: 10.1007/s11596-017-1761-5
Article

MiR-20 regulates myocardiac ischemia by targeting KATP subunit Kir6.1

Author information +
History +
PDF

Abstract

This study aimed to examine the functional role of microRNA-20 (miR-20) and its potential target, Kir6.1, in ischemic myocardiocytes. The expression of miR-20 was detected by real-time PCR. Myocardiocytes were stained with terminal deoxynucleotidyl transferase dUTP nick end labeling (TU-NEL) reagent for apoptosis evaluation. Western blotting was used to detect the Kir6.1 protein in ischemic myocardiocytes transfected with miR-20 mimics or inhibitors. Luciferase reporter gene assay was performed to confirm the targeting effect of miR-20 on KCNJ8. The results showed that miR-20 was remarkably down-regulated, while the KATP subunit Kir6.1 was significantly up-regulated, during myocardial ischemia. The miR-20 overexpression promoted the apoptosis of ischemic myocardiocytes, but showed no such effect on normal cells. Under ischemic condition, myocardiocytes transfected with miR-20 mimics expressed less Kir6.1. On the contrary, inhibiting miR-20 increased the expression of Kir6.1 in the cells. Co-transfection of miR-20 mimics with the KCNJ8 3'-UTR plasmid into HEK293 cells consistently produced less luciferase activity than transfection of the plasmid alone. It was concluded that miR-20 may regulate myocardiac ischemia by targeting KATP subunit Kir6.1 to accelerate the cell apoptosis. Therefore miR-20 may serve as a therapeutic target for myocardial ischemic disease.

Keywords

miR-20 / myocardiac ischemia / KATP / Kir6.1

Cite this article

Download citation ▾
Li Nie, Ya-nan Zhao, Hong-yan Luo, Xin-wu Hu, Liang-pin Zhang, Hua-min Liang. MiR-20 regulates myocardiac ischemia by targeting KATP subunit Kir6.1. Current Medical Science, 2017, 37(4): 486-490 DOI:10.1007/s11596-017-1761-5

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

ChistiakovDA, OrekhovAN, BobryshevYV, et al. . Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol, 2016, 94: 107-121 PMID: 27056419

[2]

ThumT, GrossC, FiedlerJ, et al. . MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 2008, 456(7224): 980-984 PMID: 19043405

[3]

ChengY, ZhuP, YangJ, et al. . Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/ reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res, 2010, 87(3): 431-439 PMID: 20219857 PMCID: 2904662

[4]

TangY, WangY, ParkKM, et al. . MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death. Cardiovasc Res, 2015, 106(3): 387-972 PMID: 25824147 PMCID: 4447807

[5]

BernardoBC, OoiJY, LinRC, et al. . miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem, 2015, 7(13): 1771-1792 PMID: 26399457

[6]

HeZ, JiangJ, KokkinakiM, et al. . MiRNA-20 and mirna-106a regulate spermatogonial stem cell renewal at the post-transcriptional level via targeting STAT3 and Ccnd1. Stem Cells, 2013, 31(10): 2205-2217 PMID: 23836497

[7]

LuoX, ZhangH, XiaoJ, et al. . Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications. Cell Physiol Biochem, 2010, 25(6): 571-586 PMID: 20511702

[8]

NieL, TangM, ZengY, et al. . Properties and functions of KATP during mouse perinatal development. Biochem Biophys Res Commun, 2012, 418(1): 74-80 PMID: 22252295

[9]

LevinMD, ZhangH, UchidaK, et al. . Electrophysiologic consequences of KATP gain of function in the heart: Conduction abnormalities in Cantu syndrome. Heart Rhythm, 2015, 12(11): 2316-24 PMID: 26142302 PMCID: 4624040

[10]

LevinMD, ZhangH, UchidaK, et al. . Electrophysiologic consequences of KATP gain of function in the heart: Conduction abnormalities in Cantu syndrome. Heart Rhythm, 2015, 12(11): 2316-2324 PMID: 26142302 PMCID: 4624040

[11]

BernardoBC, OoiJY, LinRC, et al. . miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med Chem, 2015, 7(13): 1771-1792 PMID: 26399457

[12]

YangB, LinH, XiaoJ, et al. . The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med, 2007, 13(4): 486-491 PMID: 17401374

[13]

WazaAA, AndrabiK, HussainMU. Protein kinase C (PKC) mediated interaction between conexin43 (Cx43) and K(+)(ATP) channel subunit (Kir6.1) in cardiomyocyte mitochondria: Implications in cytoprotection against hypoxia induced cell apoptosis. Cell Signal, 2014, 26(9): 1909-1917 PMID: 24815185

[14]

WeiC, WangS, YeZQ, et al. . miR-206 inhibits renal cell cancer growth by targeting GAK. J Huazhong Univ Sci Technolo, 2016, 36(6): 852-858

AI Summary AI Mindmap
PDF

118

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/